Mar Vista Says AI Could Lift Mettler-Toledo’s Pharma Growth
The investor letter said Mettler-Toledo gained 18.27% in Q3 as investors grew more optimistic about AI’s role in pharmaceutical research.
Makkler Newsroom · Oct 9, 06:10 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $1,786.36 (+2.7%)
Prices may be delayed and are for informational purposes only - not investment advice.
The investor letter said Mettler-Toledo gained 18.27% in Q3 as investors grew more optimistic about AI’s role in pharmaceutical research.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.